Padilla Carmen S, Damaj Mona B, Yang Zhong-Nan, Molina Joe, Berquist Brian R, White Earl L, Solís-Gracia Nora, Da Silva Jorge, Mandadi Kranthi K
Texas A&M AgriLife Research and Extension Center, Weslaco, TX, United States.
Institute for Plant Gene Function, Department of Biology, Shanghai Normal University, Shanghai, China.
Front Bioeng Biotechnol. 2020 Aug 18;8:977. doi: 10.3389/fbioe.2020.00977. eCollection 2020.
Sugarcane and energy cane ( spp. hybrids) are ideal for plant-based production of recombinant proteins because their high resource-use efficiency, rapid growth and efficient photosynthesis enable extensive biomass production and protein accumulation at a cost-effective scale. Here, we aimed to develop these species as efficient platforms to produce recombinant L. (snowdrop) agglutinin (GNA), a monocot-bulb mannose-specific lectin with potent antiviral, antifungal and antitumor activities. Initially, GNA levels of 0.04% and 0.3% total soluble protein (TSP) (0.3 and 3.8 mg kg tissue) were recovered from the culms and leaves, respectively, of sugarcane lines expressing recombinant under the control of the constitutive maize () promoter. Co-expression of recombinant GNA from stacked multiple promoters ( and culm-regulated promoters from sugarcane and ) on separate expression vectors increased GNA yields up to 42.3-fold (1.8% TSP or 12.7 mg kg tissue) and 7.7-fold (2.3% TSP or 29.3 mg kg tissue) in sugarcane and energy cane lines, respectively. Moreover, inducing promoter activity in the leaves of GNA transgenic lines with stress-regulated hormones increased GNA accumulation to 2.7% TSP (37.2 mg kg tissue). Purification by mannose-agarose affinity chromatography yielded a functional sugarcane recombinant GNA with binding substrate specificity similar to that of native snowdrop-bulb GNA, as shown by enzyme-linked lectin and mannose-binding inhibition assays. The size and molecular weight of recombinant GNA were identical to those of native GNA, as determined by size-exclusion chromatography and MALDI-TOF mass spectrometry. This work demonstrates the feasibility of producing recombinant GNA at high levels in species, with the long-term goal of using it as a broad-spectrum antiviral carrier molecule for hemopurifiers and in related therapeutic applications.
甘蔗和能源甘蔗(品种杂交种)是基于植物生产重组蛋白的理想选择,因为它们资源利用效率高、生长迅速且光合作用高效,能够以经济有效的规模大量生产生物质并积累蛋白质。在此,我们旨在将这些物种开发为高效平台,用于生产重组雪花莲(Galanthus nivalis)凝集素(GNA),这是一种单子叶球茎甘露糖特异性凝集素,具有强大的抗病毒、抗真菌和抗肿瘤活性。最初,在组成型玉米泛素(Ubiquitin)启动子的控制下,从表达重组GNA的甘蔗品系的茎和叶中分别回收了占总可溶性蛋白(TSP)0.04%和0.3%(0.3和3.8毫克/千克组织)的GNA水平。在单独的表达载体上,来自多个堆叠启动子(玉米泛素启动子以及甘蔗蔗糖磷酸合成酶和果糖-1,6-二磷酸酶的茎调控启动子)共表达重组GNA,使甘蔗和能源甘蔗品系中的GNA产量分别提高了42.3倍(1.8% TSP或12.7毫克/千克组织)和7.7倍(2.3% TSP或29.3毫克/千克组织)。此外,用胁迫调节激素诱导GNA转基因品系叶片中的启动子活性,使GNA积累量增加到2.7% TSP(37.2毫克/千克组织)。通过甘露糖-琼脂糖亲和层析纯化得到了一种功能性甘蔗重组GNA,其结合底物特异性与天然雪花莲球茎GNA相似,这通过酶联凝集素和甘露糖结合抑制试验得以证明。通过尺寸排阻色谱法和基质辅助激光解吸电离飞行时间质谱法测定,重组GNA的大小和分子量与天然GNA相同。这项工作证明了在甘蔗品种中高水平生产重组GNA的可行性,其长期目标是将其用作血液净化器的广谱抗病毒载体分子以及用于相关治疗应用。